{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:08:58Z","timestamp":1778260138251,"version":"3.51.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K08070"],"award-info":[{"award-number":["JP19K08070"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K10186"],"award-info":[{"award-number":["JP16K10186"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41380-025-03162-2","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:29:31Z","timestamp":1755620971000},"page":"739-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u03b17 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-8167","authenticated-orcid":false,"given":"Tomoyasu","family":"Wakuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Yokokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Magata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7997-1955","authenticated-orcid":false,"given":"Chie","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Tamayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Kameno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-8222","authenticated-orcid":false,"given":"Toshiki","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1523-3703","authenticated-orcid":false,"given":"Takashi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9715-4636","authenticated-orcid":false,"given":"Yuya","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-5508","authenticated-orcid":false,"given":"Tatsuhiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nori","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-0614","authenticated-orcid":false,"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-6317","authenticated-orcid":false,"given":"Hidenori","family":"Yamasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"3162_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473\u201386.","journal-title":"Lancet"},{"key":"3162_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/2045125318781475","volume":"8","author":"PM Haddad","year":"2018","unstructured":"Haddad PM, Correll CU. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses. Ther Adv Psychopharmacol. 2018;8:303\u201318.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3162_CR3","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318.","journal-title":"Mol Psychiatry"},{"key":"3162_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0079-6123(03)45007-3","volume":"145","author":"M Alkondon","year":"2004","unstructured":"Alkondon M, Albuquerque EX. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res. 2004;145:109\u201320.","journal-title":"Prog Brain Res"},{"key":"3162_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0306-4522(02)00223-3","volume":"113","author":"A Graham","year":"2002","unstructured":"Graham A, Court JA, Martin-Ruiz CM, Jaros E, Perry R, Volsen SG, et al. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience. 2002;113:493\u2013507.","journal-title":"Neuroscience"},{"key":"3162_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","volume":"36","author":"KT Dineley","year":"2015","unstructured":"Dineley KT, Pandya AA, Yakel JL. Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci. 2015;36:96\u2013108.","journal-title":"Trends Pharmacol Sci"},{"key":"3162_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","volume":"122","author":"SC Leiser","year":"2009","unstructured":"Leiser SC, Bowlby MR, Comery TA, Dunlop J. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther. 2009;122:302\u201311.","journal-title":"Pharmacol Ther"},{"key":"3162_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","volume":"38","author":"R Freedman","year":"1995","unstructured":"Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 1995;38:22\u201333.","journal-title":"Biol Psychiatry"},{"key":"3162_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","volume":"73","author":"J Court","year":"1999","unstructured":"Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem. 1999;73:1590\u20137.","journal-title":"J Neurochem"},{"key":"3162_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1097\/00001756-199906030-00028","volume":"10","author":"ZZ Guan","year":"1999","unstructured":"Guan ZZ, Zhang X, Blennow K, Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 1999;10:1779\u201382.","journal-title":"Neuroreport"},{"key":"3162_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0891-0618(01)00117-X","volume":"22","author":"A Marutle","year":"2001","unstructured":"Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, et al. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat. 2001;22:115\u201326.","journal-title":"J Chem Neuroanat"},{"key":"3162_CR12","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0006-3223(03)00348-2","volume":"54","author":"CM Martin-Ruiz","year":"2003","unstructured":"Martin-Ruiz CM, Haroutunian VH, Long P, Young AH, Davis KL, Perry EK, et al. Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry. 2003;54:1222\u201333.","journal-title":"Biol Psychiatry"},{"key":"3162_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108053","volume":"170","author":"AV Terry Jr","year":"2020","unstructured":"Terry AV Jr, Callahan PM. alpha7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: update on animal and clinical studies and strategies for the future. Neuropharmacology. 2020;170:108053.","journal-title":"Neuropharmacology"},{"key":"3162_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/13543784.2020.1764938","volume":"29","author":"K Antonio-Tolentino","year":"2020","unstructured":"Antonio-Tolentino K, Hopkins CR. Selective \u03b17 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review. Expert Opin Investig Drugs. 2020;29:603\u201310.","journal-title":"Expert Opin Investig Drugs"},{"key":"3162_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.631589","volume":"12","author":"M Recio-Barbero","year":"2021","unstructured":"Recio-Barbero M, Segarra R, Zabala A, Gonzalez-Fraile E, Gonzalez-Pinto A, Ballesteros J. Cognitive enhancers in schizophrenia: a systematic review and meta-analysis of alpha-7 nicotinic acetylcholine receptor agonists for cognitive deficits and negative symptoms. Front Psychiatry. 2021;12:631589.","journal-title":"Front Psychiatry"},{"key":"3162_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/ijnp\/pyy021","volume":"21","author":"DF Wong","year":"2018","unstructured":"Wong DF, Kuwabara H, Horti AG, Roberts JM, Nandi A, Cascella N, et al. Brain PET imaging of alpha7-nAChR with [18F]ASEM: reproducibility, occupancy, receptor density, and changes in schizophrenia. Int J Neuropsychopharmacol. 2018;21:656\u201367.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3162_CR17","doi-asserted-by":"publisher","first-page":"e2427163","DOI":"10.1001\/jamanetworkopen.2024.27163","volume":"7","author":"NR Wong","year":"2024","unstructured":"Wong NR, Rubin LH, Harrington CK, Jenkins KR, Shinehouse LK, Yoon M, et al. Hippocampal availability of the alpha7 nicotinic acetylcholine receptor in recent-onset psychosis. JAMA Netw Open. 2024;7:e2427163.","journal-title":"JAMA Netw Open"},{"key":"3162_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bcp.2015.07.032","volume":"97","author":"J Egea","year":"2015","unstructured":"Egea J, Buendia I, Parada E, Navarro E, Le\u00f3n R, Lopez MG. Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochem Pharmacol. 2015;97:463\u201372.","journal-title":"Biochem Pharmacol"},{"key":"3162_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12031-012-9719-3","volume":"48","author":"JX Shen","year":"2012","unstructured":"Shen JX, Yakel JL. Functional \u03b17 nicotinic ACh receptors on astrocytes in rat hippocampal CA1 slices. J Mol Neurosci. 2012;48:14\u201321.","journal-title":"J Mol Neurosci"},{"key":"3162_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10753-020-01396-6","volume":"44","author":"YJ Wu","year":"2021","unstructured":"Wu YJ, Wang L, Ji CF, Gu SF, Yin Q, Zuo J. The role of \u03b17nAChR-mediated cholinergic anti-inflammatory pathway in immune cells. Inflammation. 2021;44:821\u201334.","journal-title":"Inflammation"},{"key":"3162_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1471-4159.2004.02347.x","volume":"89","author":"RD Shytle","year":"2004","unstructured":"Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem. 2004;89:337\u201343.","journal-title":"J Neurochem"},{"key":"3162_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/jnr.20850","volume":"83","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Hide I, Matsubara A, Hama C, Harada K, Miyano K, et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C\/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res. 2006;83:1461\u201370.","journal-title":"J Neurosci Res"},{"key":"3162_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/ars.2012.4671","volume":"19","author":"E Parada","year":"2013","unstructured":"Parada E, Egea J, Buendia I, Negredo P, Cunha AC, Cardoso S, et al. The microglial \u03b17-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxid Redox Signal. 2013;19:1135\u201348.","journal-title":"Antioxid Redox Signal"},{"key":"3162_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2:258\u201370.","journal-title":"Lancet Psychiatry"},{"key":"3162_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/0004867419835028","volume":"53","author":"M Cho","year":"2019","unstructured":"Cho M, Lee TY, Kwak YB, Yoon YB, Kim M, Kwon JS. Adjunctive use of anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Aust N Z J Psychiatry. 2019;53:742\u201359.","journal-title":"Aust N Z J Psychiatry"},{"key":"3162_CR26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S2215-0366(20)30255-8","volume":"7","author":"JH Meyer","year":"2020","unstructured":"Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020;7:1064\u201374.","journal-title":"Lancet Psychiatry"},{"key":"3162_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopsych.2018.02.1171","volume":"84","author":"P Plaven-Sigray","year":"2018","unstructured":"Plaven-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, et al. Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data. Biol Psychiatry. 2018;84:433\u201342.","journal-title":"Biol Psychiatry"},{"key":"3162_CR28","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1038\/s41380-020-0829-y","volume":"26","author":"S Conen","year":"2021","unstructured":"Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-Zuelli F, Deakin B, et al. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry. 2021;26:5398\u2013406.","journal-title":"Mol Psychiatry"},{"key":"3162_CR29","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association; 2013."},{"key":"3162_CR30","volume-title":"Wechsler adult intelligence scale 3rd edition (WAIS-III)","author":"D Wechsler","year":"1997","unstructured":"Wechsler D. Wechsler adult intelligence scale 3rd edition (WAIS-III). Lisse: Swets & Zeitlinger: Netherland; 1997."},{"key":"3162_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","volume":"23","author":"CR Breese","year":"2000","unstructured":"Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, et al. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 2000;23:351\u201364.","journal-title":"Neuropsychopharmacology"},{"key":"3162_CR32","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/npp.2017.48","volume":"42","author":"AL Brody","year":"2017","unstructured":"Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, et al. Effect of cigarette smoking on a marker for neuroinflammation: a [(11)C]DAA1106 positron emission Tomography study. Neuropsychopharmacology. 2017;42:1630\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3162_CR33","volume-title":"SCID-5-CV: structured clinical interview for DSM-5 disorders : clinician version","author":"MB First","year":"2016","unstructured":"First MB, Williams JBW, Karg RS, Spitzer RL. SCID-5-CV: structured clinical interview for DSM-5 disorders : clinician version. Washington, DC: American Psychiatric Association Pub.; 2016."},{"key":"3162_CR34","volume-title":"Two factor index of social class measurement","author":"A Hollingshead","year":"1957","unstructured":"Hollingshead A. Two factor index of social class measurement. New Haven, CT: Yale University; 1957."},{"key":"3162_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/schbul\/sbu001","volume":"40","author":"S Leucht","year":"2014","unstructured":"Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull. 2014;40:314\u201326.","journal-title":"Schizophr Bull"},{"key":"3162_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/pcn.12275","volume":"69","author":"T Inada","year":"2015","unstructured":"Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69:440\u20137.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3162_CR37","first-page":"1475","volume":"18","author":"A Inagaki","year":"2015","unstructured":"Inagaki A, Inada T. Dose equivalence of depot antipsychotics IV: aripiprazole once-monthly. Jpn J Clin Psychopharmacol. 2015;18:1475\u201380.","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"3162_CR38","first-page":"91","volume":"25","author":"A Inagaki","year":"2022","unstructured":"Inagaki A, Inada T. Dose equivalence of novel antipsychotics: brexpiprazole. Jpn J Clin Psychopharmacol. 2022;25:91\u201398.","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"3162_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1440-1819.2006.01510.x","volume":"60","author":"K Matsuoka","year":"2006","unstructured":"Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y. Estimation of premorbid IQ in individuals with Alzheimer\u2019s disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci. 2006;60:332\u20139.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3162_CR40","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1017\/S0033291721004645","volume":"53","author":"CB Flaaten","year":"2023","unstructured":"Flaaten CB, Melle I, Gardsjord E, Bjella T, Engen MJ, Vaskinn A, et al. Course of intellectual functioning in schizophrenia and bipolar disorder: a 10-year Follow-Up study. Psychol Med. 2023;53:2662\u201370.","journal-title":"Psychol Med"},{"key":"3162_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull"},{"key":"3162_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/arclin\/acp010","volume":"24","author":"P Maruff","year":"2009","unstructured":"Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009;24:165\u201378.","journal-title":"Arch Clin Neuropsychol"},{"key":"3162_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1080\/13803390802592458","volume":"31","author":"RH Pietrzak","year":"2009","unstructured":"Pietrzak RH, Olver J, Norman T, Piskulic D, Maruff P, Snyder PJ. A comparison of the CogState schizophrenia battery and the measurement and treatment research to improve cognition in schizophrenia (MATRICS) battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol. 2009;31:848\u201359.","journal-title":"J Clin Exp Neuropsychol"},{"key":"3162_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2004.09.004","volume":"72","author":"RS Kern","year":"2004","unstructured":"Kern RS, Green MF, Nuechterlein KH, Deng BH. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res. 2004;72:11\u201319.","journal-title":"Schizophr Res"},{"key":"3162_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","volume":"165","author":"KH Nuechterlein","year":"2008","unstructured":"Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203\u201313.","journal-title":"Am J Psychiatry"},{"key":"3162_CR46","doi-asserted-by":"publisher","first-page":"e20469","DOI":"10.1371\/journal.pone.0020469","volume":"6","author":"T Yoshida","year":"2011","unstructured":"Yoshida T, Suga M, Arima K, Muranaka Y, Tanaka T, Eguchi S, et al. Criterion and construct validity of the CogState schizophrenia battery in Japanese patients with schizophrenia. PLoS One. 2011;6:e20469.","journal-title":"PLoS One"},{"key":"3162_CR47","doi-asserted-by":"publisher","first-page":"e0148354","DOI":"10.1371\/journal.pone.0148354","volume":"11","author":"H Nishinaka","year":"2016","unstructured":"Nishinaka H, Nakane J, Nagata T, Imai A, Kuroki N, Sakikawa N, et al. Neuropsychological impairment and its association with violence risk in Japanese forensic psychiatric patients: a Case-Control study. PLoS One. 2016;11:e0148354.","journal-title":"PLoS One"},{"key":"3162_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RS Keefe","year":"2004","unstructured":"Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68:283\u201397.","journal-title":"Schizophr Res"},{"key":"3162_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1037\/0033-2909.133.5.833","volume":"133","author":"A Reichenberg","year":"2007","unstructured":"Reichenberg A, Harvey PD. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull. 2007;133:833\u201358.","journal-title":"Psychol Bull"},{"key":"3162_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.scog.2015.03.006","volume":"2","author":"A Benoit","year":"2015","unstructured":"Benoit A, Malla AK, Iyer SN, Joober R, Bherer L, Lepage M. Cognitive deficits characterization using the CogState research battery in first-episode psychosis patients. Schizophr Res Cogn. 2015;2:140\u20135.","journal-title":"Schizophr Res Cogn"},{"key":"3162_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271\u20136.","journal-title":"Percept Mot Skills"},{"key":"3162_CR52","first-page":"567","volume":"56","author":"M Abe","year":"2004","unstructured":"Abe M, Suzuki K, Okada K, Miura R, Fujii T, Etsurou M, et al. Normative data on tests for frontal lobe functions: trail making test, verbal fluency, Wisconsin Card Sorting Test (Keio version). No Shinkei. 2004;56:567\u201374.","journal-title":"No Shinkei"},{"key":"3162_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/01688639708403836","volume":"19","author":"M Crossley","year":"1997","unstructured":"Crossley M, D\u2019Arcy C, Rawson NS. Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol. 1997;19:52\u201362.","journal-title":"J Clin Exp Neuropsychol"},{"key":"3162_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0920-9964(03)00174-9","volume":"69","author":"C Sumiyoshi","year":"2004","unstructured":"Sumiyoshi C, Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, et al. Effect of orthography on the verbal fluency performance in schizophrenia: examination using Japanese patients. Schizophr Res. 2004;69:15\u201322.","journal-title":"Schizophr Res"},{"key":"3162_CR55","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0271678X16646788","volume":"37","author":"M Yokokura","year":"2017","unstructured":"Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, et al. Depiction of microglial activation in aging and dementia: Positron emission tomography with [(11)C]DPA713 versus [(11)C](R)PK11195. J Cereb Blood Flow Metab. 2017;37:877\u201389.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3162_CR56","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3233\/JAD-170591","volume":"61","author":"K Nakaizumi","year":"2018","unstructured":"Nakaizumi K, Ouchi Y, Terada T, Yoshikawa E, Kakimoto A, Isobe T, et al. In vivo depiction of alpha7 nicotinic receptor loss for cognitive decline in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61:1355\u201365.","journal-title":"J Alzheimers Dis"},{"key":"3162_CR57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bcp.2015.07.030","volume":"97","author":"AG Horti","year":"2015","unstructured":"Horti AG. Development of [(18)F]ASEM, a specific radiotracer for quantification of the alpha7-nAChR with positron-emission tomography. Biochem Pharmacol. 2015;97:566\u201375.","journal-title":"Biochem Pharmacol"},{"key":"3162_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X","volume":"387","author":"CR Breese","year":"1997","unstructured":"Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M, et al. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol. 1997;387:385\u201398.","journal-title":"J Comp Neurol"},{"key":"3162_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1248\/bpb.32.337","volume":"32","author":"M Ogawa","year":"2009","unstructured":"Ogawa M, Tsukada H, Hatano K, Ouchi Y, Saji H, Magata Y. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT). Biol Pharm Bull. 2009;32:337\u201340.","journal-title":"Biol Pharm Bull"},{"key":"3162_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153\u20138.","journal-title":"Neuroimage"},{"key":"3162_CR61","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839\u201351.","journal-title":"Neuroimage"},{"key":"3162_CR62","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awl156","volume":"129","author":"F Picard","year":"2006","unstructured":"Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006;129:2047\u201360.","journal-title":"Brain"},{"key":"3162_CR63","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3233\/JAD-150827","volume":"51","author":"GD Femminella","year":"2016","unstructured":"Femminella GD, Ninan S, Atkinson R, Fan Z, Brooks DJ, Edison P. Does microglial activation influence hippocampal volume and neuronal function in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia? J Alzheimers Dis. 2016;51:1275\u201389.","journal-title":"J Alzheimers Dis"},{"key":"3162_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fninf.2016.00020","volume":"10","author":"S Mathotaarachchi","year":"2016","unstructured":"Mathotaarachchi S, Wang S, Shin M, Pascoal TA, Benedet AL, Kang MS, et al. VoxelStats: a MATLAB package for multi-modal voxel-wise brain image analysis. Front Neuroinform. 2016;10:20.","journal-title":"Front Neuroinform"},{"key":"3162_CR65","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/ene.15246","volume":"29","author":"T Terada","year":"2022","unstructured":"Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, et al. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer\u2019s disease. Eur J Neurol. 2022;29:1324\u201334.","journal-title":"Eur J Neurol"},{"key":"3162_CR66","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40263-020-00765-x","volume":"34","author":"AA Dinesh","year":"2020","unstructured":"Dinesh AA, Islam J, Khan J, Turkheimer F, Vernon AC. Effects of antipsychotic drugs: cross talk between the nervous and innate immune system. CNS Drugs. 2020;34:1229\u201351.","journal-title":"CNS Drugs"},{"key":"3162_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S146114570500516X","volume":"8","author":"ND Woodward","year":"2005","unstructured":"Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol. 2005;8:457\u201372.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3162_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/13803395.2018.1488952","volume":"41","author":"M Clissold","year":"2019","unstructured":"Clissold M, Crowe SF. Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach. J Clin Exp Neuropsychol. 2019;41:26\u201342.","journal-title":"J Clin Exp Neuropsychol"},{"key":"3162_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/archpsyc.1973.04200020037004","volume":"29","author":"EF Domino","year":"1973","unstructured":"Domino EF, Krause RR, Bowers J. Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients. Arch Gen Psychiatry. 1973;29:195\u2013201.","journal-title":"Arch Gen Psychiatry"},{"key":"3162_CR70","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(77)91542-2","volume":"2","author":"ED Bird","year":"1977","unstructured":"Bird ED, Spokes EG, Barnes J, MacKay AV, Iversen LL, Shepherd M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet. 1977;2:1157\u20138.","journal-title":"Lancet"},{"key":"3162_CR71","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/archpsyc.1977.01770230061003","volume":"34","author":"PL McGeer","year":"1977","unstructured":"McGeer PL, McGeer EG. Possible changes in striatal and limbic cholinergic systems in schizophrenia. Arch Gen Psychiatry. 1977;34:1319\u201323.","journal-title":"Arch Gen Psychiatry"},{"key":"3162_CR72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature07229","volume":"455","author":"H Stefansson","year":"2008","unstructured":"Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232\u20136.","journal-title":"Nature"},{"key":"3162_CR73","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature07239","volume":"455","author":"International Schizophrenia C.","year":"2008","unstructured":"International Schizophrenia C. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455:237\u201341.","journal-title":"Nature"},{"key":"3162_CR74","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/archpsyc.59.12.1085","volume":"59","author":"S Leonard","year":"2002","unstructured":"Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002;59:1085\u201396.","journal-title":"Arch Gen Psychiatry"},{"key":"3162_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107426","volume":"205","author":"K Nakazawa","year":"2020","unstructured":"Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther. 2020;205:107426.","journal-title":"Pharmacol Ther"},{"key":"3162_CR76","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/syn.20693","volume":"63","author":"A Konradsson-Geuken","year":"2009","unstructured":"Konradsson-Geuken A, Gash CR, Alexander K, Pomerleau F, Huettl P, Gerhardt GA, et al. Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse. 2009;63:1069\u201382.","journal-title":"Synapse"},{"key":"3162_CR77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroscience.2013.09.047","volume":"255","author":"DM Bortz","year":"2013","unstructured":"Bortz DM, Mikkelsen JD, Bruno JP. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release. Neuroscience. 2013;255:55\u201367.","journal-title":"Neuroscience"},{"key":"3162_CR78","first-page":"731","volume":"55","author":"ZW Liu","year":"2003","unstructured":"Liu ZW, Yang S, Zhang YX, Liu CH. Presynaptic alpha-7 nicotinic acetylcholine receptors modulate excitatory synaptic transmission in hippocampal neurons. Sheng Li Xue Bao. 2003;55:731\u20135.","journal-title":"Sheng Li Xue Bao"},{"key":"3162_CR79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.neuroscience.2003.12.023","volume":"124","author":"LA Reno","year":"2004","unstructured":"Reno LA, Zago W, Markus RP. Release of [(3)H]-L-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices. Neuroscience. 2004;124:647\u201353.","journal-title":"Neuroscience"},{"key":"3162_CR80","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1113\/jphysiol.2008.167593","volume":"587","author":"JX Shen","year":"2009","unstructured":"Shen JX, Tu B, Yakel JL. Inhibition of \u03b17\u2010containing nicotinic ACh receptors by muscarinic M1 ACh receptors in rat hippocampal CA1 interneurones in slices. J Physiol. 2009;587:1033\u201342.","journal-title":"J Physiol"},{"key":"3162_CR81","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2020.05.034","volume":"222","author":"B Dean","year":"2020","unstructured":"Dean B, Pavey G, Scarr E. Higher levels of alpha7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia. Schizophr Res. 2020;222:283\u201390.","journal-title":"Schizophr Res"},{"key":"3162_CR82","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1176\/appi.ajp.158.6.918","volume":"158","author":"JM Crook","year":"2001","unstructured":"Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann\u2019s areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry. 2001;158:918\u201325.","journal-title":"Am J Psychiatry"},{"key":"3162_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0006-3223(00)00918-5","volume":"48","author":"JM Crook","year":"2000","unstructured":"Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation. Biol Psychiatry. 2000;48:381\u20138.","journal-title":"Biol Psychiatry"},{"key":"3162_CR84","first-page":"54","volume":"1","author":"B Dean","year":"1996","unstructured":"Dean B, Crook JM, Opeskin K, Hill C, Keks N, Copolov DL. The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol Psychiatry. 1996;1:54\u201358.","journal-title":"Mol Psychiatry"},{"key":"3162_CR85","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0024-3205(99)00114-9","volume":"64","author":"JM Crook","year":"1999","unstructured":"Crook JM, Dean B, Pavey G, Copolov D. The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia. Life Sci. 1999;64:1761\u201371.","journal-title":"Life Sci"},{"key":"3162_CR86","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.npp.1300367","volume":"29","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Katsifis A, Mattner F, Huang XF. Investigation of m1\/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology. 2004;29:619\u201325.","journal-title":"Neuropsychopharmacology"},{"key":"3162_CR87","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuroscience.2005.08.006","volume":"136","author":"AV Terry Jr","year":"2005","unstructured":"Terry AV Jr, Gearhart DA, Mahadik SP, Warsi S, Davis LW, Waller JL. Chronic exposure to typical or atypical antipsychotics in rodents: temporal effects on central alpha7 nicotinic acetylcholine receptors. Neuroscience. 2005;136:519\u201329.","journal-title":"Neuroscience"},{"key":"3162_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2007.06.007","volume":"571","author":"AV Terry Jr","year":"2007","unstructured":"Terry AV Jr, Gearhart DA. Time dependent decreases in central alpha7 nicotinic acetylcholine receptors associated with haloperidol and risperidone treatment in rats. Eur J Pharmacol. 2007;571:29\u201332.","journal-title":"Eur J Pharmacol"},{"key":"3162_CR89","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/schbul\/16.3.433","volume":"16","author":"TJ Crow","year":"1990","unstructured":"Crow TJ. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull. 1990;16:433\u201343.","journal-title":"Schizophr Bull"},{"key":"3162_CR90","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1523\/JNEUROSCI.4575-09.2010","volume":"30","author":"V Oertel","year":"2010","unstructured":"Oertel V, Knochel C, Rotarska-Jagiela A, Schonmeyer R, Lindner M, van de Ven V, et al. Reduced laterality as a trait marker of schizophrenia\u2013evidence from structural and functional neuroimaging. J Neurosci. 2010;30:2289\u201399.","journal-title":"J Neurosci"},{"key":"3162_CR91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/brainsci14030261","volume":"14","author":"HM Abdolmaleky","year":"2024","unstructured":"Abdolmaleky HM, Nohesara S, Thiagalingam S. Epigenome defines aberrant brain laterality in major mental illnesses. Brain Sci. 2024;14:261.","journal-title":"Brain Sci"},{"key":"3162_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.40","volume":"6","author":"JM Coughlin","year":"2016","unstructured":"Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016;6:e777.","journal-title":"Transl Psychiatry"},{"key":"3162_CR93","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00259-021-05248-9","volume":"49","author":"C Wimberley","year":"2021","unstructured":"Wimberley C, Lavisse S, Hillmer A, Hinz R, Turkheimer F, Zanotti-Fregonara P. Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain. Eur J Nucl Med Mol Imaging. 2021;49:246\u201356.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3162_CR94","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/mp.2017.232","volume":"23","author":"T Notter","year":"2018","unstructured":"Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry. 2018;23:36\u201347.","journal-title":"Mol Psychiatry"},{"key":"3162_CR95","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","volume":"49","author":"E Nutma","year":"2021","unstructured":"Nutma E, Ceyz\u00e9riat K, Amor S, Tsartsalis S, Millet P, Owen DR, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021;49:146\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3162_CR96","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1176\/ajp.155.8.1056","volume":"155","author":"VA Curtis","year":"1998","unstructured":"Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry. 1998;155:1056\u201363.","journal-title":"Am J Psychiatry"},{"key":"3162_CR97","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1037\/0894-4105.14.3.353","volume":"14","author":"ML Gourovitch","year":"2000","unstructured":"Gourovitch ML, Kirkby BS, Goldberg TE, Weinberger DR, Gold JM, Esposito G, et al. A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology. 2000;14:353\u201360.","journal-title":"Neuropsychology"},{"key":"3162_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312462120","volume":"120","author":"NB Lundin","year":"2023","unstructured":"Lundin NB, Brown JW, Johns BT, Jones MN, Purcell JR, Hetrick WP, et al. Neural evidence of switch processes during semantic and phonetic foraging in human memory. Proc Natl Acad Sci USA. 2023;120:e2312462120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3162_CR99","first-page":"386","volume":"13","author":"P Marien","year":"2014","unstructured":"Marien P, Ackermann H, Adamaszek M, Barwood CH, Beaton A, Desmond J, et al. Consensus paper: language and the cerebellum: an ongoing enigma. Cerebellum. 2014;13:386\u2013410.","journal-title":"Cerebellum"},{"key":"3162_CR100","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nucmedbio.2009.11.007","volume":"37","author":"M Ogawa","year":"2010","unstructured":"Ogawa M, Nishiyama S, Tsukada H, Hatano K, Fuchigami T, Yamaguchi H, et al. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor \u03b17 subtype. Nucl Med Biol. 2010;37:347\u201355.","journal-title":"Nucl Med Biol"},{"key":"3162_CR101","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","volume":"45","author":"S Selvaraj","year":"2014","unstructured":"Selvaraj S, Arnone D, Cappai A, Howes O. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev. 2014;45:233\u201345.","journal-title":"Neurosci Biobehav Rev"},{"key":"3162_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03162-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:38Z","timestamp":1768849298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03162-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3162"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03162-2","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}